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The role of melatonin in preventing ovarian tissue damage in rats exposed to magnetic fields
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Objectives: We observed the efficacy of melatonin in preventing ovarian tissue damage in rats exposed to magnetic fields.
Materials and methods: Forty rats were divided into four treatment groups: Group 1, control group (n = 10); Group 2, melatonin
administration only (n = 10); Group 3, magnetic field exposure only (n = 10); Group 4, magnetic field exposure with melatonin
administration (n = 10). The magnetic field was applied at a dose of 20 µT for 30 min/day for 10 days. Melatonin was orally administered
at a dose of 10 mg/kg. We evaluated follicle count, degree of fibrosis, amount of adhesion, amount of apoptosis, ovarian dimensions, and
follicular degeneration by dissecting the ovaries of the rats on day 11, and differences among the groups were evaluated.
Results: Group 3 had an increased amount of follicle degeneration, more fibrosis, and more adhesion than Group 4, but these findings
were not statistically significant. The apoptosis scores in Groups 1 and 2 were significantly lower than in the other groups. Ovarian
dimensions were significantly decreased in Group 3. Follicular degeneration was significantly increased in Group 3.
Conclusion: Exogenously administered melatonin, if used at much higher doses orally, may be a noncytotoxic, antiapoptotic agent and
may also have a protective effect on ovarian tissue damage that radiation can cause at the level of fine structure.
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1. Introduction
As a consequence of technological improvements,
exposure to magnetic fields has been increasing. The
harmful effects of chronic exposure to magnetic fields can
be observed in all tissues of the human body, particularly
in the ovaries (1,2).
Damage in ovarian tissues due to magnetic fields is
generally associated with an increase in free radicals and
oxidant production and a decrease in antioxidant capacity
(3–5). With increased exposure to magnetic fields, reactive
oxygen species (ROS) increase in the ovaries and most
other tissues of the body (4). ROS affect cell proliferation
and differentiation and cause apoptosis and necrosis (6,7).
ROS also have direct toxic effects on cells, leading to lipid
peroxidation, protein oxidation, and DNA damage. As a
result, neurodegeneration, cellular aging, cancer, chronic
inflammatory pathologies, and ovarian pathologies occur
(8–11).
Melatonin
(N-acetyl-5-methoxytryptamine),
an
important nonenzymatic antioxidant hormone produced
by the pineal gland, has a circadian rhythm that is
generated by the circadian pacemaker situated in the

suprachiasmatic nucleus (SCN) of the hypothalamus,
synchronized to 24 h primarily by the light/dark cycle
via the SCN (12). Once synthesized, melatonin is quickly
released into the bloodstream and then into other body
fluids, such as the cerebrospinal fluid, semen, amniotic
fluid, and ovarian follicular fluid (13). Melatonin has
many functions in organisms, such as regulating seasonal
reproduction (14).
It has been shown that melatonin is a powerful free
radical scavenger and a broad-spectrum antioxidant (15).
Melatonin crosses all cell membranes easily because of its
small size and highly lipophilic nature and is found at high
concentrations in subcellular compartments, including
mitochondria and nuclei (16,17). Melatonin plays a role in
preventing lipid peroxidation and damage to protein and
DNA, and in maintaining optimal mitochondrial function
(18,19) and homeostasis by reducing or preventing
mitochondrial oxidative stress, which causes subsequent
apoptotic events and cell death (20,21). Melatonin and
its metabolites (i.e. cyclic 3-hydroxymelatonin, N1acetyl-N2-formyl-5-methoxykynuramine,
and
N1acetyl-5-methoxykynuramine) are excellent direct
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scavengers of toxic reactants and free radicals including
superoxide, hydroxyl, singlet oxygen, hydrogen peroxide,
hypochlorous acid, nitric oxide, and peroxynitrite anion
(18). In addition, melatonin plays an important role
in activating antioxidant markers such as superoxide
dismutase (SOD), catalase (CAT), glutathione peroxidase
(GPx), glutathione reductase (GSH-Rd), and glucose-6phosphate dehydrogenase (G6PD) (22).
This study was designed to investigate whether damage
to ovaries induced by exposure to a magnetic field is
inhibited by the administration of melatonin, a protective
antioxidant that has a role in regulating ovarian function.
2. Materials and methods
Forty Wistar albino rats, ranging in weight from 150 to 200
g, were included in this study. During the experiment, the
rats were kept in wire mesh cages with a grid size of 30 × 60
× 30 cm, each of which housed 10 rats. The rats were given
ad libitum access to food (Feeding Foundation Standard
Pellet Rat Feed) and tap water in a 12-h light/dark cycle.
Standard room temperature (22 ± 1 °C) and humidity were
maintained.
Permission to perform the study was obtained
from the local ethics committee of Ankara Education and
Training Hospital. The 40 rats were categorized into four
treatment groups:
Group 1: Control group (n = 10)
Group 2: Melatonin administration (10 mg/kg) only (n
= 10)
Group 3: Magnetic field exposure (20 µT/day) only (n
= 10)
Group 4: Melatonin administration (10 mg/kg) +
magnetic field exposure (20 µT/day) (n = 10)
We generated the magnetic field by passing current
through a bobbin. The magnitude of the magnetic field
generated was calculated with the formula B = k × I/R,
where B = magnetic field, k = constant, I = current, and R =
wire length. The ammeter was set at 2.40 A with a rheostat
while the applied magnetic field was produced. In the
assembly, the coil, rheostat, voltmeter, and ammeter were
connected in a series. The coil was placed at the midpoint
of the rat cages to provide the same amount of exposure to
all animals. Thirty minutes after the administration of the
melatonin, the magnetic field was applied for 30 min at a
dose of 20 µT for 10 days.
Melatonin was added to a solution consisting of 16.2
mL of saline and 1.8 mL of alcohol. This mixture was
applied orally at a dose of 10 mg/kg via nasogastric tube 30
min prior to exposure to the magnetic field.
After the rats were euthanized on day 11, their
abdomens were opened with a vertical incision and
the ovaries were removed under sterile conditions. We
collected the extracted materials in saline-containing
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containers to perform histological examinations. After
detoxification in 5% formic acid solution, tissues were
processed and sections were taken from the prepared
paraffin blocks with a thickness of 4 mm and stained with
hematoxylin and eosin. The sections were evaluated under
an Olympus BX51 microscope for the number of mature
follicles, adhesion, fibrosis, apoptosis, ovarian size, and
follicular degeneration.
2.1. Histopathological examination
Histomorphological characteristics were evaluated using
the following scoring system:
Number of mature follicles: 1–5 = 1 point, 6–10 = 2
points, ≥11 = 3 points.
Adhesion: None = 0 points, partial = 1 point, significant
= 2 points.
Fibrosis: None = 0 points, partial = 1 point, common
= 2 points.
Apoptosis: None = 0 points, partial = 1 point, common
= 2 points.
Ovarian size: Atrophied = 1 point, normal = 2 points.
Follicular degeneration: None = 0 points, partial = 1
point, common = 2 points.
2.2. Statistical analysis
All data are expressed as median (min–max). Differences
between the arithmetic means of the parameters studied
in the biological material obtained from the rats were
compared statistically using SPSS 15.0 for Windows (SPSS
Inc., Chicago, IL, USA). Differences among the groups
were assessed using Kruskal–Wallis analysis. Increases
in weight were assessed using the Wilcoxon signed rank
test. Significance was set at P < 0.05 for all statistical
comparisons.
3. Results
The number of mature follicles was relatively lower in Group
3 than in Group 1 (P < 0.001). The control group (Group
1) and melatonin-only group (Group 2) had less adhesion
than the groups exposed to the magnetic field (Groups 3
and 4; P < 0.005). Group 3 had the highest adhesion score.
Fibrosis scores were significantly lower in Groups 1 and 2
than in Groups 3 and 4 (P < 0.001) (Table 1).
Apoptosis scores were significantly lower in Groups 1
and 2 than in Groups 3 and 4 (P = 0.001). The ovarian sizes
were higher in Groups 1 and 2 than in the other groups.
The ovarian size of Group 3 was significantly smaller than
that of the other groups (P < 0.001; Table 1).
Follicular degeneration was significantly lower
in Groups 1 and 2 than in the other groups, but no
significant differences were observed among the other
groups (Figure 1). When we examined the groups
in terms of follicular degeneration, we observed the
greatest amount of degeneration in Group 3 (Figure 2).
When compared to the group receiving only radiation,
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Table 1. Histomorphometric scores of groups.
Group

Number of
mature follicles

Adhesion score

Fibrosis score

Apoptosis score

Ovarian
dimension

Follicular
degeneration score

Group 1

3 (3–3) a,b

0 (0–0) a,e

0 (0–0) a,b

0 (0–0) a,e

2 (2–2) a,g

0 (0–0) a,e

Group 2

3 (3–3)

0 (0–0)

0 (0–0)

0 (0–0)

2 (2–2)

0 (0–0) c,f

Group 3

1 (1–2) a,c

1 (1–2) a,c

2 (1–2) a,c

2 (1–2) a,c

Group 4

2 (2–2)

1 (1–1)

2 (1–2)

1 (1–1.5)

P-value

<0.001

c,d

b,d

<0.001

c,f

e,f

c,f

b,f

<0.001

c,f

e,f

<0.001

c,h

1 (1–1) a,c

2 (1.5–2) a,c

1 (1–2)

1 (1–2) e,f

<0.001

g,h

<0.001

The difference between Group 1 and Group 3 was statistically significant (P < 0.001).
The difference between Group 1 and Group 4 was statistically significant (P = 0.004).
c
The difference between Group 2 and Group 3 was statistically significant (P < 0.001).
d
The difference between Group 2 and Group 4 was statistically significant (P = 0.004).
e
The difference between Group 1 and Group 4 was statistically significant (P < 0.001).
f
The difference between Group 2 and Group 4 was statistically significant (P < 0.001).
g
The difference between Group 1 and Group 4 was statistically significant (P = 0.018).
h
The difference between Group 2 and Group 4 was statistically significant (P = 0.018).
a

b

Figure 1. Normal ovarian tissue.

it was observed that the application of melatonin
caused an increase in the number of follicles (Figure 3).
4. Discussion
Prolonged exposure to magnetic fields has become
part of daily life in recent years owing to technological
developments and the increasing use of these technologies.
However, such exposure may have adverse effects on the
reproductive system. Although the mechanism underlying
the toxic effects of magnetic fields on tissues is not yet
clearly understood, it is thought to cause damage by
increasing tissue temperatures and inducing oxidative
stress, which leads to a breakdown in communication
between cells (23).
In a study assessed in 2008, the long-term application
(2 hours/day for 10 months) of magnetic fields of 100 and
500 µT, which are considered to be the safety limits for the

public and employees, respectively, were investigated for
oxidative DNA damage and the low-frequency magnetic
field was shown to cause oxidative DNA damage (24).
The safety margin in Turkey is 200 µT. In our study, the
applied magnetic field was 20 µT considering the body
area of the rats. In our study, even at this low level, the
significant follicle degeneration, size reduction, and
increased apoptosis in cells suggests that this safety limit
value should be further reduced. We applied the magnetic
field for 10 days. Although it is very difficult to indicate the
tendency to transform into cancer during this process, as
follicle degeneration increases, the appearance of cancer
cells is a predictable parameter according to the studies
performed.
In studies that suggested that magnetic fields lead
to ovarian tissue damage, exposure to magnetic fields
caused ovarian atresia, shrinkage and changes in shape
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Figure 2. Ovarian tissue from the group that received radiation exposure only. The
atrophic appearance of the ovary and the lack of follicles are remarkable.

Figure 3. Ovarian tissue from the group that received melatonin before radiation
exposure. When compared to the group receiving only radiation, it is observed that the
application of melatonin caused an increase in the number of follicles.

of oocyte nuclei, decreased numbers of ovarian follicles,
and DNA damage (1,2,25,26). In our study, we similarly
found significant degeneration in mature follicles in the
group exposed to radiation. We also observed a significant
decrease in the number of ovarian follicles and ovarian
atresia. Recent studies have found that magnetic fields
increase apoptosis by inducing oxidative stress in uteri and
ovaries (27,28). In an in vitro study, magnetic fields caused
DNA damage in rat granulosa cells and significantly
decreased ovarian size (29). Ferchichi et al. also showed in
their study that ovarian sizes significantly decreased in rats
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exposed to magnetic fields (30). In 1999, Kim et al. showed
that radiation caused cell apoptosis and impaired ovarian
functions (31). In our study, we observed a significant
increase in follicular degeneration, apoptosis, fibrosis, and
adhesion scores and a significant decrease in ovarian size
in groups exposed to magnetic fields. When we applied
melatonin as an antioxidant, we found that there was not
any significant recovery.
Melatonin is a powerful antioxidant that eliminates the
damaging effects of free radicals that are formed in parallel
with the metabolic rhythm (32). Because it is small enough
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to easily pass through biological membranes, melatonin
can access all of the organelles of a cell and easily prevent
injuries to lipids, proteins, and DNA. Recent studies have
shown that melatonin significantly prevents follicular
degeneration, follicular atresia, oxidative stress, and
apoptosis and reduces mitochondrial dysfunction in the
ovaries. It also protects granulosa cells from oxidative stress
(33–36). In a study by Vijayalaxmi et al., it was determined
that the use of 300 mg of oral melatonin prevented
DNA damage, reduced chromosomal aberrations, and
reduced micronuclei development (37). In our study, we
administered 10 mg/kg melatonin to rats 30 min before
radiation exposure to prevent damage induced by the
magnetic field. Melatonin was dissolved in solution and
applied orally with nasogastric tube. We adjusted the dose
of melatonin by adapting the doses used in humans and the
study of Onal et al. about the effect of melatonin on bowel
mucosal damage. In humans, melatonin is used orally in
doses of 3–6 mg for sleep disorders. In the study carried
out by Onal et al. in 2010, it was assessed that 15 mg/kg i.p.
applied melatonin prevented bowel damage (38).
In our study, follicular degeneration, apoptosis, fibrosis,
and adhesions were significantly increased and ovarian size
was significantly reduced in the group receiving radiation.
The number of mature follicles in the melatonin-receiving
group was not different from that of the control, indicating
that melatonin did not corrupt the ovarian tissue and had
no degenerative effect. Ovarian damage was less severe in
rats that received melatonin compared to those that did
not, but it was seen that radiation-induced damage was not
prevented to a significant extent.
In our study, there was a significant increase in
immature follicles and a significant degeneration of
mature follicles in the radiation-receiving group. Although
there was a partial decrease in immature follicles with the
administration of melatonin with radiation, there was no

statistically significant result. Kaya et al. (39) also showed
a 42% and 12% increase in the number of primordial and
antral follicles, whereas the precentral staining was not
significant, 16 h after radiation. Jarrell et al. (40) and Ataya
et al. (41) also reported that preantral follicles showed
nearly normal morphology after radiation applications.
Although it was not statistically significant, the number
of mature follicles was higher in the group receiving
melatonin and radiation than in the group receiving only
radiation. Adhesion scores were significantly increased
in the group receiving radiation. Adhesion, fibrosis, and
apoptosis scores of the melatonin and radiation group were
decreased when compared with the radiation-receiving
group, but this was not statistically significant. Although
we assessed the protective effect of melatonin in the ovary,
it was not statistically significant. The reason for this may
be that we used a low dosage of melatonin or had an
insufficient sample size. Oral bioavailability of melatonin
is considered to be lower than intraperitoneal use. Because
the effect of radiation on ovarian tissue is very high, we
believe that if preradiation melatonin is to be used orally,
it should be used at much higher doses (100–300 mg) than
the 2 mg used in routine settings.
In conclusion, we found that melatonin, an exogenous
agent, is a noncytotoxic, antiapoptotic agent. There may
also be a protective effect by reducing the impact of free
radicals on the ovarian tissue damage at the fine structure
level that radiation application can generate. Prophylactic
melatonin may be useful for preventing ovarian tissue
damage and consequent development of female infertility
that may occur as a result of increased exposure to
magnetic fields. However, melatonin should be used at a
much higher dose than the oral dose. Our work should
be supported by immunohistochemical studies with new
antibodies to demonstrate cellular degeneration.
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